Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Net Income (2016 - 2025)

Conmed's Net Income history spans 16 years, with the latest figure at $16.7 million for Q4 2025.

  • For Q4 2025, Net Income fell 50.41% year-over-year to $16.7 million; the TTM value through Dec 2025 reached $47.1 million, down 64.47%, while the annual FY2025 figure was $47.1 million, 64.47% down from the prior year.
  • Net Income reached $16.7 million in Q4 2025 per CNMD's latest filing, up from $2.9 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of $49.0 million in Q3 2024 to a low of -$168.3 million in Q2 2022.
  • Average Net Income over 5 years is $11.3 million, with a median of $16.3 million recorded in 2023.
  • Peak YoY movement for Net Income: crashed 1366.3% in 2022, then soared 983.51% in 2024.
  • A 5-year view of Net Income shows it stood at $24.4 million in 2021, then grew by 8.75% to $26.6 million in 2022, then grew by 24.4% to $33.1 million in 2023, then grew by 2.07% to $33.8 million in 2024, then tumbled by 50.41% to $16.7 million in 2025.
  • Per Business Quant, the three most recent readings for CNMD's Net Income are $16.7 million (Q4 2025), $2.9 million (Q3 2025), and $21.4 million (Q2 2025).